OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

ADCT

Stock ticker: NYSE

PRICE

CHANGE

CAPITALIZATION

ADC Therapeutics SA (ADCT) Earnings Date & Reports

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ADCT is expected to report earnings to rise 81.82% to -40 cents per share on August 12

ADC Therapeutics SA ADCT Stock Earnings Reports

Q2'25

Est.

$-0.40

Q1'25

Beat

by $0.18

Q4'24

Beat

by $0.18

Q3'24

Beat

by $0.10

Q2'24

Beat

by $0.08

The last earnings report on May 14 showed earnings per share of -21 cents, beating the estimate of -40 cents. With 637.35K shares outstanding, the current market capitalization sits at 341.17M.

View a ticker or compare two or three

Compare

ADCT

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ADCT
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

View to see Real Time Patterns for ADCT (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

Route de la Corniche 3B

Phone

+41 216530200

Employees

274

Web

https://www.adctherapeutics.com